These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
623 related articles for article (PubMed ID: 21774961)
1. BRAF(V600E) mutation analysis of liquid-based preparation-processed fine needle aspiration sample improves the diagnostic rate of papillary thyroid carcinoma. Chang H; Lee H; Yoon SO; Kim H; Kim A; Kim BH Hum Pathol; 2012 Jan; 43(1):89-95. PubMed ID: 21774961 [TBL] [Abstract][Full Text] [Related]
2. Pyrosequencing analysis for detection of a BRAFV600E mutation in an FNAB specimen of thyroid nodules. Kim SK; Kim DL; Han HS; Kim WS; Kim SJ; Moon WJ; Oh SY; Hwang TS Diagn Mol Pathol; 2008 Jun; 17(2):118-25. PubMed ID: 18382358 [TBL] [Abstract][Full Text] [Related]
3. Detection of BRAFV600E mutation on fine needle aspiration specimens of thyroid nodule refines cyto-pathology diagnosis, especially in BRAF600E mutation-prevalent area. Chung KW; Yang SK; Lee GK; Kim EY; Kwon S; Lee SH; Park DJ; Lee HS; Cho BY; Lee ES; Kim SW Clin Endocrinol (Oxf); 2006 Nov; 65(5):660-6. PubMed ID: 17054470 [TBL] [Abstract][Full Text] [Related]
4. Detection of the BRAF(V600E) mutation in fine needle aspiration cytology of thyroid papillary microcarcinoma cells selected by manual macrodissection: an easy tool to improve the preoperative diagnosis. Marchetti I; Iervasi G; Mazzanti CM; Lessi F; Tomei S; Naccarato AG; Aretini P; Alberti B; Di Coscio G; Bevilacqua G Thyroid; 2012 Mar; 22(3):292-8. PubMed ID: 22181337 [TBL] [Abstract][Full Text] [Related]
5. Preparation of thyroid FNA material for routine cytology and BRAF testing: a validation study. Troncone G; Cozzolino I; Fedele M; Malapelle U; Palombini L Diagn Cytopathol; 2010 Mar; 38(3):172-6. PubMed ID: 19693938 [TBL] [Abstract][Full Text] [Related]
6. Dual priming oligonucleotide-based multiplex PCR analysis for detection of BRAFV600E mutation in FNAB samples of thyroid nodules in BRAFV600E mutation-prevalent area. Kwak JY; Kim EK; Kim JK; Han JH; Hong SW; Park TS; Choi JR Head Neck; 2010 Apr; 32(4):490-8. PubMed ID: 19672964 [TBL] [Abstract][Full Text] [Related]
7. BRAF (V600E) mutation analysis on liquid-based cytology-processed aspiration biopsies predicts bilaterality and lymph node involvement in papillary thyroid microcarcinoma. Rossi ED; Martini M; Capodimonti S; Lombardi CP; Pontecorvi A; Vellone VG; Zannoni GF; Larocca LM; Fadda G Cancer Cytopathol; 2013 Jun; 121(6):291-7. PubMed ID: 23192956 [TBL] [Abstract][Full Text] [Related]
8. [BRAF V600E mutation in papillary thyroid carcinoma: prevalence and detection in fine needle aspiration specimens]. Dujardin F; Pagès JC; Collin C; de Calan L; Lecomte P; Guyétant S Ann Pathol; 2010 Aug; 30(4):252-62. PubMed ID: 20837233 [TBL] [Abstract][Full Text] [Related]
9. Uncommon BRAF mutations in the follicular variant of thyroid papillary carcinoma: New insights. Rossi ED; Martini M; Bizzarro T; Capodimonti S; Cenci T; Lombardi CP; Pontecorvi A; Fadda G; Larocca LM Cancer Cytopathol; 2015 Oct; 123(10):593-602. PubMed ID: 26230187 [TBL] [Abstract][Full Text] [Related]
10. Reduction of false-negative papillary thyroid carcinomas by the routine analysis of BRAF(T1799A) mutation on fine-needle aspiration biopsy specimens: a prospective study of 814 thyroid FNAB patients. Cañadas-Garre M; Becerra-Massare P; López de la Torre-Casares M; Villar-del Moral J; Céspedes-Mas S; Vílchez-Joya R; Muros-de Fuentes T; García-Calvente C; Piédrola-Maroto G; López-Nevot MA; Montes-Ramírez R; Llamas-Elvira JM Ann Surg; 2012 May; 255(5):986-92. PubMed ID: 22504197 [TBL] [Abstract][Full Text] [Related]
11. A morpho-molecular diagnosis of papillary thyroid carcinoma: BRAF V600E detection as an important tool in preoperative evaluation of fine-needle aspirates. Marchetti I; Lessi F; Mazzanti CM; Bertacca G; Elisei R; Coscio GD; Pinchera A; Bevilacqua G Thyroid; 2009 Aug; 19(8):837-42. PubMed ID: 19534623 [TBL] [Abstract][Full Text] [Related]
12. Detection of BRAF c.1799T > A (p.V600E) mutation using residual routine fine-needle aspiration specimens of papillary thyroid carcinoma. Zhao H; Zhang ZH; Zhou B; Xiao T; Pan QJ; Guo HQ Diagn Cytopathol; 2015 Oct; 43(10):786-90. PubMed ID: 26152656 [TBL] [Abstract][Full Text] [Related]
13. Detection of BRAF V600E mutation in thyroid fine-needle aspiration specimens by High Resolution Melting (HRM) analysis. Nechifor-Boilă A; Decaussin-Petrucci M; Gazzo S; Paşcanu I; Borda A Rom J Morphol Embryol; 2012; 53(2):263-7. PubMed ID: 22732794 [TBL] [Abstract][Full Text] [Related]
14. BRAF mutation analysis in fine needle aspiration (FNA) cytology of the thyroid. Jin L; Sebo TJ; Nakamura N; Qian X; Oliveira A; Majerus JA; Johnson MR; Lloyd RV Diagn Mol Pathol; 2006 Sep; 15(3):136-43. PubMed ID: 16932068 [TBL] [Abstract][Full Text] [Related]
15. BRAF mutational analysis in papillary carcinomas with mixed follicular and papillary growth patterns. Jakubowski M; Hunt JL Am J Surg Pathol; 2009 Nov; 33(11):1590-3. PubMed ID: 19738460 [TBL] [Abstract][Full Text] [Related]
16. False-negative BRAF V600E mutation results on fine-needle aspiration cytology of papillary thyroid carcinoma. Paek SH; Kim BS; Kang KH; Kim HS World J Surg Oncol; 2017 Nov; 15(1):202. PubMed ID: 29132392 [TBL] [Abstract][Full Text] [Related]
17. BRAF V600E mutation analysis of thyroid nodules needle aspirates in relation to their ultrasongraphic classification: a potential guide for selection of samples for molecular analysis. Nam SY; Han BK; Ko EY; Kang SS; Hahn SY; Hwang JY; Nam MY; Kim JW; Chung JH; Oh YL; Shin JH Thyroid; 2010 Mar; 20(3):273-9. PubMed ID: 20187782 [TBL] [Abstract][Full Text] [Related]
18. Clinical implication of highly sensitive detection of the BRAF V600E mutation in fine-needle aspirations of thyroid nodules: a comparative analysis of three molecular assays in 4585 consecutive cases in a BRAF V600E mutation-prevalent area. Lee ST; Kim SW; Ki CS; Jang JH; Shin JH; Oh YL; Kim JW; Chung JH J Clin Endocrinol Metab; 2012 Jul; 97(7):2299-306. PubMed ID: 22500044 [TBL] [Abstract][Full Text] [Related]
19. [Expression of BRAF V600E mutation in different thyroid lesions]. Wang W; Li XH; Zhang YH; Li J; Chen J; Zhao P; Li QY; Xiang JJ; Li X; Xu RJ Zhonghua Zhong Liu Za Zhi; 2011 May; 33(5):354-7. PubMed ID: 21875464 [TBL] [Abstract][Full Text] [Related]
20. Pyrosequencing cut-off value identifying BRAFV600E mutation in fine needle aspiration samples of thyroid nodules. Yeo MK; Liang ZL; Oh T; Moon Y; An S; Kim MK; Kim KS; Shong M; Kim JM; Jo YS Clin Endocrinol (Oxf); 2011 Oct; 75(4):555-60. PubMed ID: 21609347 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]